Epidemiology

Global Paroxysmal Nocturnal Hemoglobinuria Report 2021 - Develop In-depth Knowledge of Competition and Markets - ResearchAndMarkets.com

Retrieved on: 
Wednesday, September 22, 2021
Health, Pharmaceutical, Research, G7, Paroxysmal nocturnal hemoglobinuria, Epidemiology, Competitive landscape, Paroxysmal attack, Fine chemical, Pharmaceutical industry

The "Global Paroxysmal Nocturnal Hemoglobinuria Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Paroxysmal Nocturnal Hemoglobinuria Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.
  • This report provides comprehensive insights into Paroxysmal Nocturnal Hemoglobinuria pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.
  • This research covers the following - Paroxysmal Nocturnal Hemoglobinuria treatment options, Paroxysmal Nocturnal Hemoglobinuria late-stage clinical trials pipeline, Paroxysmal Nocturnal Hemoglobinuria prevalence by countries, Paroxysmal Nocturnal Hemoglobinuria market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries.
  • Paroxysmal Nocturnal Hemoglobinuria pipeline: Find out drugs in clinical trials for the treatment of Paroxysmal Nocturnal Hemoglobinuria by development phase 3, phase 2, by pharmacological class and company
    Paroxysmal Nocturnal Hemoglobinuria drugs: Identify key drugs marketed and prescribed for Paroxysmal Nocturnal Hemoglobinuria in the US, including trade name, molecule name, and company
    Paroxysmal Nocturnal Hemoglobinuria drugs sales: Find out the sales value for Paroxysmal Nocturnal Hemoglobinuria drugs by countries
    Paroxysmal Nocturnal Hemoglobinuria market valuations: Find out the market size for Paroxysmal Nocturnal Hemoglobinuria drugs in 2020 by countries.

Outlook on the Thalassemia Global Market to 2026 - Market Shares for Key Drugs - ResearchAndMarkets.com

Retrieved on: 
Wednesday, September 22, 2021
Health, Pharmaceutical, Research, G7, Epidemiology, Prevalence, Competitive landscape, Pharmaceutical industry

The "Global Thalassemia Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Thalassemia Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.
  • This report provides comprehensive insights into Thalassemia pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.
  • This research analyzes and forecasts Thalassemia market size and drug sales.
  • This research covers the following - Thalassemia treatment options, Thalassemia late-stage clinical trials pipeline, Thalassemia prevalence by countries, Thalassemia market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries.

Anemia Epidemiology Forecast to 2030 with Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 21, 2021
IDA, Health education, Man, Food, Health, Patient, Pathology, Western world, Epidemiology, Total, Woman, Prevalence, Chronic kidney disease, Dietary supplement, Pharmaceutical industry

This 'Iron deficiency anemia (IDA)- Epidemiology Forecast to 2030' report delivers an in-depth understanding of the IDA across the several selected cancer types, historical and forecasted IDA epidemiology in the 7MM, i.e., the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Key Points: 
  • This 'Iron deficiency anemia (IDA)- Epidemiology Forecast to 2030' report delivers an in-depth understanding of the IDA across the several selected cancer types, historical and forecasted IDA epidemiology in the 7MM, i.e., the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
  • The IDA epidemiology division provides the insights about historical and current indication wise eligible patient pool and forecasted trend for each seven major countries.
  • Among all the pathology related cause of IDA, IDA in chronic kidney disease have the highest patient pool in 2020.
  • Moreover, the model supports data presented in the report and showcases disease trends over 10-year forecast period using reputable sources

Europe Depression Market and Competitive Landscape Report 2021-2026 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 21, 2021
Pharmaceutical, Health, Mental Health, Research, Epidemiology, Prevalence, Depression, Competitive landscape, Pharmaceutical industry

The "Europe Depression Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Europe Depression Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.
  • Europe Depression Market and Competitive Landscape - 2021, provides comprehensive insights into Depression pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.
  • This research analyzes and forecasts Depression market size and drug sales.
  • This research covers the following - Depression treatment options, Depression late-stage clinical trials pipeline, Depression prevalence by countries, Depression market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries.

Human Papillomavirus 16-Positive (HPV16+) Cancers Epidemiology Forecast to 2030 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 21, 2021
Infectious Diseases, Pharmaceutical, Health, Oncology, Cancer, Patient, Population, Epidemiology, United Kingdom, HPV, Vaccine, Renewable energy

The "Human Papillomavirus 16-Positive (HPV16+) Cancers - Epidemiology Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Human Papillomavirus 16-Positive (HPV16+) Cancers - Epidemiology Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • This 'HPV 16+ Cancer -Epidemiology Forecast - 2030' report delivers an in-depth understanding of HPV 16+ cancer, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
  • The HPV 16+ Cancer epidemiology division provides insights into the historical and current patient pool and the forecasted trend for every seven major countries.
  • The disease epidemiology covered in the report provides historical as well as forecasted HPV 16+ Cancer epidemiology segmented as the Incident Cases of HPV-induced cancer.

X-Linked Retinitis Pigmentosa (XLRP) Epidemiology Forecast to 2030 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 21, 2021
Health, Pharmaceutical, Table, Epidemiology, Retinitis pigmentosa, Disease, United Kingdom, Tourism, Dentistry

The "X-Linked Retinitis Pigmentosa (XLRP) - Epidemiology Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "X-Linked Retinitis Pigmentosa (XLRP) - Epidemiology Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • The 'X-Linked Retinitis Pigmentosa (XLRP) - Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical and forecasted X-Linked Retinitis Pigmentosa (XLRP) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
  • The X-Linked Retinitis Pigmentosa (XLRP) epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030.
  • The X-Linked Retinitis Pigmentosa (XLRP) epidemiology covered in the report provides historical as well as forecasted X-Linked Retinitis Pigmentosa (XLRP) epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan from 2017 to 2030.

Global Total Knee Replacement Market (2021 to 2026) - Featuring Corin, Exactech and Stryker Among Others - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 21, 2021
Medical Devices, Health, Tendon, CAGR, Ageing, Health technology, Population, Low back pain, Arthritis, Osteoarthritis, Joint, Environment, Diabetes, Osteomyelitis, Industry, Epidemiology, Company, Osteoporosis, Obesity, Incidence, Investment, Projection, Muscle, Dentistry, Risk management

This report examines the current and forecasted market potential for total knee replacement.

Key Points: 
  • This report examines the current and forecasted market potential for total knee replacement.
  • It offers a detailed analysis of the market background, technological advancement, competitive environment, drivers and restraints, and market growth trends.
  • This report includes market projections through 2026, detailing the market share for total knee replacement based on the product and implant type.
  • Also, the increasing incidence of orthopedic disorders related to the growing incidence of both diabetes and obesity cases is pushing growth in the total knee replacement market.

Global Gastroparesis Drug Pipeline Guide and Competitive Landscape 2021 - ResearchAndMarkets.com

Retrieved on: 
Monday, September 20, 2021
Health, Pharmaceutical, Research, G7, Epidemiology, Prevalence, Competitive landscape, Pharmaceutical industry

The "Global Gastroparesis Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Gastroparesis Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.
  • The latest research provides comprehensive insights into Gastroparesis pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.
  • This research analyzes and forecasts Gastroparesis market size and drug sales.
  • This research covers the following - Gastroparesis treatment options, Gastroparesis late-stage clinical trials pipeline, Gastroparesis prevalence by countries, Gastroparesis market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries.

Global Irritable Bowel Syndrome Pipeline Guide 2021 - ResearchAndMarkets.com

Retrieved on: 
Monday, September 20, 2021
General Health, Pharmaceutical, Health, Other Health, Irritable bowel syndrome, Research, G7, Epidemiology, Prevalence, Competitive landscape, Gum arabic, Pharmaceutical industry

The "Global Irritable Bowel Syndrome Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Irritable Bowel Syndrome Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.
  • The latest research provides comprehensive insights into Irritable Bowel Syndrome pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.
  • This research covers the following - Irritable Bowel Syndrome treatment options, Irritable Bowel Syndrome late-stage clinical trials pipeline, Irritable Bowel Syndrome prevalence by countries, Irritable Bowel Syndrome market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries.
  • Irritable Bowel Syndrome pipeline: Find out drugs in clinical trials for the treatment of Irritable Bowel Syndrome by development phase 3, phase 2, by pharmacological class and company
    Irritable Bowel Syndrome drugs: Identify key drugs marketed and prescribed for Irritable Bowel Syndrome in the US, including trade name, molecule name, and company
    Irritable Bowel Syndrome drugs sales: Find out the sales value for Irritable Bowel Syndrome drugs by countries
    Irritable Bowel Syndrome market valuations: Find out the market size for Irritable Bowel Syndrome drugs in 2020 by countries.

Europe Acne Market, Competitive Landscape and Pipeline Guide 2021 - ResearchAndMarkets.com

Retrieved on: 
Monday, September 20, 2021
Cosmetics, Retail, Research, Epidemiology, Prevalence, Competitive landscape, Pharmaceutical industry

The "Europe Acne Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Europe Acne Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.
  • The report provides comprehensive insights into Acne pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.
  • This research analyzes and forecasts Acne market size and drug sales.
  • This research covers the following - Acne treatment options, Acne late-stage clinical trials pipeline, Acne prevalence by countries, Acne market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries.